Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans

ISSN： 2041-6792

Source： Clinical Investigation, Vol.3, Iss.7, 2013-07, pp. : 637-650

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E1-E11

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recent Clinical Trials of mTOR-Targeted Cancer Therapies

Reviews on Recent Clinical Trials, Vol. 6, Iss. 1, 2011-01 ,pp. : 24-35

Bentham Science Publishers

Access to resources Recommend Favorite

Medication use by adolescents and adults with fragile X syndrome

JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, Vol. 62, Iss. 2, 2018-02 ,pp. : 94-105

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current Status of Clinical Trials for Glioblastoma

Reviews on Recent Clinical Trials, Vol. 1, Iss. 3, 2006-09 ,pp. : 265-281

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Trials of Targeted Alpha Therapy for Cancer

Reviews on Recent Clinical Trials, Vol. 3, Iss. 3, 2008-09 ,pp. : 185-191

Bentham Science Publishers

Access to resources Recommend Favorite